2019 annual financial data
Scinai Immunotherapeutics 2019 Net income growth
Direct answer
Net income growth was -34.79%.
Operating income was -22,689,000 USD and net income was -31,620,000 USD.
Operating cash flow was -22,314,308 USD.
Get free Scinai Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,689,000 USD
- Net income
- -31,620,000 USD
- Operating cash flow
- -22,314,308 USD